A REVIEW OF CURRENT AND UPCOMING TREATMENT MODALITIES IN NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS

Para ver esta información, visualizar aquí 

Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. Research trends in obesity & obesogenic environments in Korea